The investigational gene therapy ST-920 (isaralgagene civaparvovec) has been well tolerated so far among adults with…
Articles by Marisa Wexler, MS
Among people receiving medical care for chronic kidney diseases, a small fraction have Fabry disease, a new study highlights.
Over the past two decades, kidney disease and urinary tract problems have become more common among people with Fabry…
The first Fabry disease patient has been dosed in a Phase 2 clinical trial that’s testing the experimental oral…
A team of expert clinicians and patient advocates has created a new set of recommendations to guide the use of…
People with Fabry disease who have burning limb pain or depression are more likely to report poor quality of…
A gene therapy treatment increased levels of the deficient alpha-glactosidase A (Gal A) enzyme in the organs of mice in…
Enzyme replacement therapy (ERT) can help to increase the bone density of male patients with Fabry disease, who…
An imaging technology called 3D echocardiography, which allows clinicians to visualize the heart in three dimensions and measure the strain…
People with Fabry disease commonly have abnormalities in the brain’s blood vessels, such as unusually thick vessel walls or…